River blindness: Upper East Health Directorate targets 164,525 people for treatment

- Advertisement -

The Upper East Regional Health Directorate is targeting 164,525 people across four districts for treatment against Onchocerciasis, commonly known as river blindness, as part of the second round of the 2026 Mass Drug Administration (MDA) campaign.

The exercise, scheduled from November 15 to 28, 2026, will cover Bawku West, Builsa South, Kassena-Nankana West and Tempane districts, where an estimated 205,656 people are at risk of contracting the disease.

Trained health workers and community volunteers will distribute Ivermectin tablets to eligible residents through a house-to-house exercise aimed at improving treatment coverage and reducing the spread of the disease.

Speaking during a media engagement at the Regional Health Directorate in Bolgatanga on November 12, 2026, the Upper East Regional Director of Health Services, Dr Braimah Baba Ababakari, called for public cooperation to ensure the success of the campaign.

“As part of our efforts to strengthen public awareness, promote community participation and mobilise support for the successful implementation of the campaign across the targeted districts in the Upper East Region, we have engaged the media to help us educate the public,” he said.

Dr Ababakari explained that Onchocerciasis is one of several Neglected Tropical Diseases (NTDs) affecting vulnerable populations, particularly people living in rural and underserved communities.

The disease is caused by the parasitic worm Onchocerca volvulus and transmitted through the bite of infected blackflies, which breed in fast-flowing rivers and streams.

According to him, Neglected Tropical Diseases affect more than one billion people globally and contribute to poverty, stigma, physical disabilities, disfigurement and discrimination.

“Ghana is endemic for 14 out of the 21 Neglected Tropical Diseases identified by the World Health Organization,” he stated.

Dr Ababakari explained that Mass Drug Administration involves providing medicines to eligible people in affected communities to prevent and control specific diseases.

He disclosed that the second round of the 2026 Onchocerciasis campaign would be implemented in 86 districts across 15 regions of Ghana, targeting approximately 6.3 million people.

In the Upper East Region, 14 sub-districts across the four participating districts have been identified for the intervention.

The Regional Health Director said the distribution of Ivermectin would be accompanied by community sensitisation and mobilisation activities to encourage participation.

“Improved treatment coverage is essential to achieving the elimination of Onchocerciasis. We therefore urge all eligible persons to cooperate with the health workers and community drug distributors when they visit their homes,” he appealed.

He also urged residents to report any adverse reactions after taking the medication to community drug distributors or the nearest health facility for appropriate medical attention.

“If anyone experiences any adverse reaction after taking the medicine, we encourage that person to report immediately to the community drug distributor or the nearest health facility so that the appropriate attention can be given,” he said.

Dr Ababakari further appealed to media organisations, religious leaders, assembly members and traditional authorities in the participating districts to support public education and community mobilisation efforts.

The campaign forms part of ongoing efforts to improve treatment coverage and eliminate river blindness as a public health problem in affected communities.

A1 Radio | 101.1 MHz | Joseph Napoleon Anaaya | Bolgatanga

- Advertisement -

MOST POPULAR

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related news

- Advertisement -